Ciprofloxacin/Celecoxib Combination in Patients With ALS

Clinical trial NCT04090684 · COMPLETED

Trial details

NCT number: NCT04090684
Sponsor: NeuroSense Therapeutics Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

ALS (Amyotrophic Lateral Sclerosis)

Start date: 2019-12-09
Primary completion: 2021-09-27
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.